Omega-3 fatty acids show early promise for prostate enlargement, but the evidence is thin and almost entirely indirect. No large randomized trial has tested omega-3 supplements as a standalone treatment for benign prostatic hyperplasia (BPH). What does exist is a plausible biological story linking omega-3s to the inflammatory processes that drive prostate growth, one small clinical trial showing benefit when omega-3s were added to standard BPH medications, and a separate body of research on prostate cancer that complicates the picture in unexpected ways.
Why Inflammation Matters for Prostate Enlargement
BPH has traditionally been explained as a hormone-driven process: testosterone and its potent byproduct dihydrotestosterone (DHT) stimulate prostate cells to multiply as men age. That explanation is real but incomplete. Over the past two decades, researchers have built a strong case that chronic inflammation inside the prostate is a co-driver of the enlargement, not just a bystander.
Several inflammatory signaling molecules appear to directly promote prostate tissue growth. Two in particular, interleukin-17 and interleukin-8 (IL-17 and IL-8), have been linked to both tissue remodeling and smooth muscle contraction within the gland, which together worsen the urinary symptoms men experience.1PubMed Central. Chronic inflammation in benign prostatic hyperplasia: Pathophysiology and treatment options The sources of this inflammation vary. Bacterial infections, urine reflux into the prostatic ducts, autoimmune responses, hormonal shifts, and even reduced oxygen supply to the tissue can all spark or sustain the inflammatory cycle.2PubMed Central. Role of inflammation in benign prostatic hyperplasia
IL-8 deserves special mention because it appears to act as a direct growth signal for prostate stromal cells, the structural cells that make up much of the enlarged tissue. Research suggests that immune cells already present in the inflamed prostate release a cocktail of signals that drive stromal cells to secrete IL-8, which then loops back to stimulate more cell proliferation.3PubMed. Chronic inflammation in the pathogenesis of benign prostatic hyperplasia This self-reinforcing cycle helps explain why BPH tends to get progressively worse over years rather than reaching a plateau.
This is where omega-3 fatty acids enter the conversation. EPA and DHA, the two main long-chain omega-3s found in fish and fish oil supplements, are well established as anti-inflammatory agents throughout the body. If chronic inflammation is helping to drive prostate growth, then anything that dials down that inflammation could theoretically slow the process. The logic is sound. The question is whether the biology actually plays out that way in the prostate.
The One Clinical Trial That Tested This Directly
Only one published clinical trial has specifically examined omega-3 supplementation in men with BPH and lower urinary tract symptoms (LUTS). In that study, men already taking the standard BPH drug combination of tamsulosin and finasteride were split into two groups. One group added omega-3 fatty acid capsules to their regimen; the other continued on the two drugs alone. Both groups improved, but the men taking omega-3s on top of their medications showed significantly greater improvement in symptom scores, peak urinary flow rate, and average flow rate. Those advantages appeared within one month and persisted through six months of follow-up.4PubMed. Combination therapy with omega-3 fatty acids plus tamsulocin and finasteride in the treatment of men with lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH)
That result is encouraging but comes with serious caveats. It was a single study, and the omega-3s were tested only as an add-on to existing drugs, not on their own. We have no way to know from this alone whether omega-3s would do anything meaningful for a man not already on medication. The study also cannot tell us whether the benefit came from omega-3s shrinking the prostate, reducing inflammation-driven swelling, relaxing smooth muscle, or some combination. And as with any single small trial, the results could be a statistical fluke that would not hold up in a larger replication.
What Preclinical Research Suggests About the Mechanism
Animal and lab studies offer a clearer window into how omega-3s interact with prostate tissue, even though these findings do not automatically translate to human BPH treatment.
In mouse models, dietary omega-3 supplementation reduced gene expression of several inflammatory markers in prostate tissue, including IL-6 and TNF-alpha, two cytokines heavily implicated in prostate inflammation.5PubMed Central. Effect of Dietary Omega-3 Fatty Acids on Tumor-Associated Macrophages and Prostate Cancer Progression Those particular studies focused on tumor-bearing prostates rather than BPH, but the inflammatory pathways overlap substantially. If omega-3s can quiet the same signals in a non-cancerous but inflamed prostate, the downstream effect on tissue growth could be meaningful.
Separately, researchers studying prostate tissue directly found that EPA and its oxidized metabolites were inversely correlated with prostate tumor volume, meaning higher tissue EPA levels tracked with smaller growths. In contrast, arachidonic acid metabolites and other omega-6-derived compounds correlated positively with larger tissue volume.6Prostaglandins, Leukotrienes and Essential Fatty Acids. Long chain omega-3 fatty acids and their oxidized metabolites are associated with reduced prostate tumor growth Again, this was studied in the context of cancer, not BPH. But the underlying inflammatory and growth-promoting pathways share enough biology that these findings are considered relevant to benign enlargement as well.
A study of men with BPH found that several markers of oxidative stress derived from omega-6 fatty acids, along with certain inflammation-resolving molecules derived from omega-3s, were significantly elevated compared to healthy controls. The pattern suggests that the body is actively trying to resolve prostate inflammation using omega-3-derived molecules but not fully succeeding, especially in men who also have metabolic syndrome.7PubMed Central. The profile of oxidative stress markers (arachidonic and linoleic acid derivatives) in patients with benign prostatic hyperplasia in relation to metabolic syndrome
The Omega-6 to Omega-3 Ratio May Matter More Than Omega-3 Alone
A recurring theme in this research is that the balance between omega-6 and omega-3 fatty acids may be more important than the absolute amount of omega-3 you consume. The modern Western diet is heavily skewed toward omega-6 fats, found in vegetable oils, processed foods, and grain-fed meat. Omega-6s are not inherently harmful, but when the ratio gets too lopsided, the inflammatory side of the equation overwhelms the anti-inflammatory side.
In prostate cancer models, maintaining a low omega-6 to omega-3 ratio suppressed several growth-promoting cellular pathways and induced cell death in cancer cells.8PubMed. A low dietary ratio of omega-6 to omega-3 Fatty acids may delay progression of prostate cancer Dietary pattern reviews have similarly noted that diets high in omega-3s and low in total fat, particularly omega-6-rich fat, are associated with reduced prostate health risk, while high-fat diets rich in omega-6s point in the opposite direction.9Molecular Nutrition & Food Research. Correlations of dietary patterns with prostate health
This has a practical implication for anyone thinking about taking fish oil for prostate health. Adding an omega-3 supplement while continuing to eat a diet drenched in soybean oil, fried food, and processed snacks may not shift the ratio enough to matter. The supplement is trying to push in one direction while the rest of the diet pushes harder in the other. Reducing omega-6 intake simultaneously is probably necessary for the omega-3s to have their best chance at an anti-inflammatory effect in the prostate.
The Prostate Cancer Scare That Muddied the Waters
If you search for omega-3 and prostate health, you will almost certainly encounter alarming headlines from around 2013. A large analysis of blood samples from the SELECT trial, a major cancer prevention study, found that men with the highest blood levels of long-chain omega-3 fatty acids had a roughly 43% higher risk of prostate cancer compared to men with the lowest levels.10JNCI: Journal of the National Cancer Institute. Plasma Phospholipid Fatty Acids and Prostate Cancer Risk in the SELECT Trial The association held for both low-grade and high-grade disease, with high-grade cancer risk nearly 71% higher in the top quartile.
Those numbers generated widespread worry, and they deserve to be taken seriously. But the study had several features that make it hard to interpret as a causal warning against omega-3 consumption. It was observational, meaning it measured blood fatty acid levels at a single time point and then tracked cancer diagnoses. It could not distinguish whether the omega-3s caused the cancer, whether some other factor in high-fish-consuming men drove the association, or whether the relationship was coincidental. The absolute differences in blood omega-3 levels between the highest and lowest quartiles were small, and the study did not collect dietary data or supplement information in a way that could pin the association to fish oil specifically.
Other research has pointed in the opposite direction. When EPA was measured directly in prostate tissue rather than in blood, men with higher tissue EPA levels had dramatically lower odds of aggressive cancer progression during active surveillance. After adjusting for age, PSA, and other factors, men in the highest third of prostate tissue EPA had a fraction of the cancer progression risk compared to men in the lowest third.11Cancer Prevention Research. Prostatic and Dietary Omega-3 Fatty Acids and Prostate Cancer Progression during Active Surveillance
The contradiction between these findings is not fully resolved. One possibility is that blood levels of omega-3s are a poor proxy for what is actually happening in prostate tissue. Another is that the SELECT finding was confounded by unmeasured variables. What can be said with reasonable confidence is that the SELECT result has not been confirmed by intervention trials showing that taking omega-3 supplements causes prostate cancer. The concern remains on the radar of researchers, but it has not translated into medical guidelines advising men to avoid omega-3s for prostate health reasons.
The Gut Microbiome Connection
An emerging line of research suggests that omega-3 fatty acids may influence the prostate not just through direct anti-inflammatory effects in the tissue, but also indirectly through the gut. A 2024 study found that omega-3 supplementation with a specific EPA formulation altered the gut microbiome in both mice and human prostate cancer patients, reducing the abundance of a bacterial family called Ruminococcaceae by about 12% and lowering fecal butyric acid levels. These gut changes correlated with reduced tumor growth in mice and a lower rate of cancer upgrading at surgery in patients.12Nature Communications. The gut microbiome-prostate cancer crosstalk is modulated by dietary polyunsaturated long-chain fatty acids
This is still early-stage science, and the study focused on cancer rather than BPH. But the broader principle is relevant: the gut microbiome shapes systemic inflammation, and systemic inflammation affects the prostate. If omega-3s can reconfigure the gut in ways that lower the body’s overall inflammatory tone, BPH could benefit downstream. It is a speculative chain of reasoning with some biological plausibility, and researchers are actively investigating it.
Metabolic Syndrome and Why Your Waistline Matters
BPH does not happen in a vacuum. Men with metabolic syndrome, the cluster of conditions including abdominal obesity, high blood sugar, abnormal cholesterol, and high blood pressure, tend to have worse BPH and more severe urinary symptoms. The link is likely mediated in part by the systemic inflammation and oxidative stress that metabolic syndrome produces.
The BPH oxidative stress study mentioned earlier found a significant relationship between metabolic syndrome and levels of certain lipid-derived inflammatory markers in men with prostate enlargement.7PubMed Central. The profile of oxidative stress markers (arachidonic and linoleic acid derivatives) in patients with benign prostatic hyperplasia in relation to metabolic syndrome This suggests that metabolic health and prostate health are intertwined through shared inflammatory pathways.
Omega-3 fatty acids are among the better-studied interventions for metabolic syndrome-related inflammation, particularly for lowering triglycerides. So there may be a secondary benefit: even if omega-3s do not act directly on the prostate in a clinically meaningful way, improving the metabolic environment in which the prostate exists could slow the inflammatory cascade that feeds BPH. Weight loss, blood sugar control, and exercise have all been linked to improved urinary symptoms in men with BPH, and omega-3s could be one piece of that broader metabolic puzzle.
What Omega-3s Cannot Do for You
It is worth being direct about the limits. No evidence supports using omega-3 supplements as a replacement for standard BPH medications like alpha-blockers or 5-alpha reductase inhibitors. If your prostate is enlarged enough to cause bothersome symptoms, particularly difficulty starting urination, a weak stream, frequent nighttime trips to the bathroom, or incomplete bladder emptying, those are problems that established treatments address and omega-3s alone do not. The one clinical trial that showed benefit used omega-3s on top of medications, not instead of them.
Fish oil supplements also vary enormously in quality. The amount of EPA and DHA per capsule, the ratio between the two, the degree of oxidation (rancidity) in the product, and the presence of contaminants all differ across brands. A cheap, oxidized fish oil might be pro-inflammatory rather than anti-inflammatory, which would obviously defeat the purpose. If you do choose to supplement, third-party tested products with verified EPA and DHA content and low oxidation markers are a safer bet.
The quality of your overall diet almost certainly matters more than any single supplement. A man eating a standard high-omega-6 diet and dropping a fish oil capsule on top of it is making a marginal intervention at best. The dietary pattern research consistently points toward a broader shift: more fish, fewer fried and processed foods, more vegetables, less red meat, and in general a lower ratio of omega-6 to omega-3 fats across the whole diet.9Molecular Nutrition & Food Research. Correlations of dietary patterns with prostate health
When to Talk to a Doctor Instead of Reaching for a Supplement
Prostate enlargement is extremely common in men over 50, and many cases are mild enough that no treatment is needed beyond monitoring. But some symptoms warrant medical attention rather than self-treatment with supplements. Blood in the urine, a sudden inability to urinate, recurrent urinary tract infections, or rapidly worsening symptoms all call for professional evaluation. BPH symptoms also overlap with those of prostate cancer and prostatitis (prostate infection), so getting a proper diagnosis before deciding on any approach, pharmaceutical or nutritional, is a genuinely important step.
For men with confirmed, mild-to-moderate BPH who are interested in anti-inflammatory dietary strategies, omega-3 supplementation is a reasonable addition to discuss with a urologist, especially alongside the better-proven lifestyle changes of weight management and physical activity. It is not a proven treatment. It is a biologically plausible, low-risk strategy that aligns with broader dietary recommendations for metabolic and cardiovascular health, and that may offer modest additional benefit for the inflamed prostate. The research is still catching up to the biology, and larger, dedicated clinical trials are needed before anything stronger can be said.